- Home
- INM vs CYBR Comparison
INM vs CYBR Comparison
Compare INM & CYBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- CYBR
- Stock Information
- Founded
- INM 1981
- CYBR 1999
- Country
- INM Canada
- CYBR Israel
- Employees
- INM 13
- CYBR N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- CYBR Computer Software: Prepackaged Software
- Sector
- INM Health Care
- CYBR Technology
- Exchange
- INM Nasdaq
- CYBR Nasdaq
- Market Cap
- INM 4.8M
- CYBR 24.0B
- IPO Year
- INM N/A
- CYBR 2014
- Fundamental
- Price
- INM $1.67
- CYBR $481.57
- Analyst Decision
- INM
- CYBR Buy
- Analyst Count
- INM 0
- CYBR 31
- Target Price
- INM N/A
- CYBR $453.23
- AVG Volume (30 Days)
- INM 62.1K
- CYBR 446.0K
- Earning Date
- INM 11-06-2025
- CYBR 11-06-2025
- Dividend Yield
- INM N/A
- CYBR N/A
- EPS Growth
- INM N/A
- CYBR N/A
- EPS
- INM N/A
- CYBR N/A
- Revenue
- INM $4,798,116.00
- CYBR $1,302,851,000.00
- Revenue This Year
- INM N/A
- CYBR $35.70
- Revenue Next Year
- INM N/A
- CYBR $19.22
- P/E Ratio
- INM N/A
- CYBR N/A
- Revenue Growth
- INM N/A
- CYBR 43.26
- 52 Week Low
- INM $1.56
- CYBR $288.63
- 52 Week High
- INM $8.27
- CYBR $526.19
- Technical
- Relative Strength Index (RSI)
- INM 34.19
- CYBR 38.73
- Support Level
- INM $1.59
- CYBR $473.27
- Resistance Level
- INM $1.91
- CYBR $520.47
- Average True Range (ATR)
- INM 0.10
- CYBR 11.84
- MACD
- INM -0.00
- CYBR -4.56
- Stochastic Oscillator
- INM 19.67
- CYBR 17.92
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About CYBR CyberArk Software Ltd.
CyberArk is a cybersecurity vendor focused on the identity market. The company's core privileged access management offering is a market leader in that subsegment, with more than half of the Fortune 500 as CyberArk customers. The identity security vendor was founded in 1999 and has around 9,000 customers across various industries. While CyberArk historically sold its security solutions primarily via on-premises licenses, over the past few years it has transitioned to a subscription recurring-revenue model.